SCHEMBL7440377

SCHEMBL7440377

COC(=O)C(NC(=O)N1CCN(Cc2ccccc2)CC1)C(C)C

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.71
CYP2C9 P11712 2/20 0.71
CYP3A4 P08684 1/20 0.71
CYP2C19 P33261 1/20 0.71
MEN1 O00255 2/20 0.68
KMT2A Q03164 2/20 0.68
FAAH O00519 7/20 0.55
KDM4E B2RXH2 1/20 0.53
MAPT P10636 1/20 0.53
POLB P06746 1/20 0.52
GFER P55789 1/20 0.52
MAPK1 P28482 1/20 0.52
HSD17B10 Q99714 1/20 0.52
ALDH1A1 P00352 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
CA12 O43570 1/20 0.51
CA2 P00918 1/20 0.51
CA9 Q16790 1/20 0.51
PKM P14618 1/20 0.50
HTT P42858 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7440380 1.00 CYP2D6 (0.71) CYP2D6CYP2C9CYP3A4CYP2C19MEN1
SCHEMBL7342675 0.89 CYP3A4 (0.61) CYP2D6CYP2C9CYP3A4CYP2C19MEN1
SCHEMBL7342680 0.89 CYP3A4 (0.61) CYP2D6CYP2C9CYP3A4CYP2C19MEN1
SCHEMBL7341211 0.81 MGLL (0.58) CYP2D6CYP2C9CYP3A4CYP2C19MEN1
SCHEMBL7341213 0.81 MGLL (0.58) CYP2D6CYP2C9CYP3A4CYP2C19MEN1
SCHEMBL7301105 0.81 HSD17B10 (0.70) CYP2C9CYP3A4CYP2C19MEN1KMT2A
SCHEMBL7301109 0.81 HSD17B10 (0.70) CYP2C9CYP3A4CYP2C19MEN1KMT2A
SCHEMBL7335199 0.81 CYP2C19 (0.58) CYP2D6CYP2C9CYP3A4CYP2C19MEN1
SCHEMBL7333266 0.81 CYP2C19 (0.58) CYP2D6CYP2C9CYP3A4CYP2C19MEN1
SCHEMBL7339472 0.81 CYP2C19 (0.58) CYP2D6CYP2C9CYP3A4CYP2C19MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0997459-A1 Intermediates for preparing retroviral protease inhibiting compounds Abbott Laboratories (US) 2000-05-03 EP disclosed
US-5837873-A PROTECTED OXYDIAMINES ABBOTT LABORATORIES (US) 1998-11-17 US disclosed
US-5616714-A PYRIDYL, THIAZOLYL-SUBSTITUTED AMINO ACID DERIVATIVES ABBOTT LABORATORIES (US) 1997-04-01 US disclosed
US-5597926-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-01-28 US disclosed
US-5554783-A (2R, 3R, 4S, 5S)-3-ACETOXY-2,5-BIS/BENZYLOXYCARBONYLAMINO/ -4-BROMO-1,5-DIPHENYLHEXANE ABBOTT LABORATORIES (US) 1996-09-10 US disclosed
US-5541334-A TREATING HIV ABBOTT LABORATORIES (US) 1996-07-30 US disclosed
US-5354866-A Treating HIV infections ABBOTT LABORATORIES (US) 1994-10-11 US disclosed
EP-0486948-A2 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1992-05-27 EP disclosed